Table 3 Relationship between expressions of survivin and its splice variants in tissues with clinical staging
From: Early diagnostic value of survivin and its alternative splice variants in breast cancer
Characteristic | n | Survivin | Survivin-2B | Survivin-ΔEx3 |
|---|---|---|---|---|
Stage II/III | 7 | +++ (62%) | +++ (0%) | +++ (50%) |
++ (27%) | ++ (25%) | ++ (50%) | ||
+ (11%) | + (50%) | + (0%) | ||
0 (0%) | 0 (25%) | 0 (0%) | ||
Stage IV | 9 | +++ (75%) | +++ (0%) | +++ (70%) |
++ (19%) | ++ (0%) | ++ (25%) | ||
+ (6%) | + (19%) | + (5%) | ||
0 (0%) | 0 (81%) | 0 (0%) |